182 related articles for article (PubMed ID: 15988473)
21. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans.
Sevak RJ; Stoops WW; Hays LR; Rush CR
J Pharmacol Exp Ther; 2009 Mar; 328(3):1007-18. PubMed ID: 19104030
[TBL] [Abstract][Full Text] [Related]
22. Aripiprazole and haloperidol suppress excessive dopamine release in the amygdala in response to conditioned fear stress, but show contrasting effects on basal dopamine release in methamphetamine-sensitized rats.
Oshibuchi H; Inada K; Sugawara H; Ishigooka J
Eur J Pharmacol; 2009 Aug; 615(1-3):83-90. PubMed ID: 19477171
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women.
Lile JA; Kendall SL; Babalonis S; Martin CA; Kelly TH
Pharmacol Biochem Behav; 2007; 87(2):258-66. PubMed ID: 17544491
[TBL] [Abstract][Full Text] [Related]
24. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
Schwabe K; Koch M
Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
[TBL] [Abstract][Full Text] [Related]
25. Discriminative-stimulus effects of modafinil in cocaine-trained humans.
Rush CR; Kelly TH; Hays LR; Wooten AF
Drug Alcohol Depend; 2002 Aug; 67(3):311-22. PubMed ID: 12127202
[TBL] [Abstract][Full Text] [Related]
26. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance.
Stoops WW; Lile JA; Lofwall MR; Rush CR
Am J Drug Alcohol Abuse; 2007; 33(6):769-76. PubMed ID: 17994473
[TBL] [Abstract][Full Text] [Related]
27. Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
Kollins SH; Rush CR
Pharmacol Biochem Behav; 1999 Oct; 64(2):319-26. PubMed ID: 10515308
[TBL] [Abstract][Full Text] [Related]
28. Effects of mu opioid agonists alone and in combination with cocaine and D-amphetamine in rhesus monkeys trained to discriminate cocaine.
Negus SS; Gatch MB; Mello NK
Neuropsychopharmacology; 1998 May; 18(5):325-38. PubMed ID: 9536446
[TBL] [Abstract][Full Text] [Related]
29. The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice.
Jerlhag E
Alcohol; 2008 Mar; 42(2):123-7. PubMed ID: 18358991
[TBL] [Abstract][Full Text] [Related]
30. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
Rush CR; Stoops WW; Hays LR
Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the discriminative stimulus effects of the D3 dopamine antagonist PNU-99194A in rats: comparison with psychomotor stimulants.
Baker LE; Miller ME; Svensson KA
Behav Pharmacol; 1997 Jun; 8(2-3):243-52. PubMed ID: 9833019
[TBL] [Abstract][Full Text] [Related]
32. The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.
Aihara K; Shimada J; Miwa T; Tottori K; Burris KD; Yocca FD; Horie M; Kikuchi T
Brain Res; 2004 Apr; 1003(1-2):9-17. PubMed ID: 15019558
[TBL] [Abstract][Full Text] [Related]
33. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans.
Stoops WW; Vansickel AR; Lile JA; Rush CR
Pharmacol Biochem Behav; 2007 May; 87(1):20-9. PubMed ID: 17490738
[TBL] [Abstract][Full Text] [Related]
34. Discriminative stimulus effects of a cocaine/heroin "speedball" combination in rhesus monkeys.
Negus SS; Gatch MB; Mello NK
J Pharmacol Exp Ther; 1998 Jun; 285(3):1123-36. PubMed ID: 9618415
[TBL] [Abstract][Full Text] [Related]
35. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
Etievant A; Bétry C; Arnt J; Haddjeri N
Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
[TBL] [Abstract][Full Text] [Related]
36. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period.
Lile JA; Stoops WW; Hays LR; Rush CR
Am J Drug Alcohol Abuse; 2008; 34(6):721-9. PubMed ID: 18855244
[TBL] [Abstract][Full Text] [Related]
37. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.
Shapiro DA; Renock S; Arrington E; Chiodo LA; Liu LX; Sibley DR; Roth BL; Mailman R
Neuropsychopharmacology; 2003 Aug; 28(8):1400-11. PubMed ID: 12784105
[TBL] [Abstract][Full Text] [Related]
38. Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
Wood MD; Scott C; Clarke K; Westaway J; Davies CH; Reavill C; Hill M; Rourke C; Newson M; Jones DN; Forbes IT; Gribble A
Eur J Pharmacol; 2006 Sep; 546(1-3):88-94. PubMed ID: 16925992
[TBL] [Abstract][Full Text] [Related]
39. The antipsychotic aripiprazole selectively prevents the stimulant and rewarding effects of morphine in mice.
Almeida-Santos AF; Gobira PH; Souza DP; Ferreira RC; Romero TR; Duarte ID; Aguiar DC; Moreira FA
Eur J Pharmacol; 2014 Nov; 742():139-44. PubMed ID: 25218988
[TBL] [Abstract][Full Text] [Related]
40. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Rush CR; Kollins SH; Pazzaglia PJ
Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
